EPAS1 and metabolic dysfunction-associated steatotic liver disease: Moreover, we have reported that HIF-2α is over-expressed in two third of HCC developing in NAFLD patients with HIF-2α nuclear localization beeing prevalent in HCCs originating in cirrhotic livers [14].